Business Summary
|
Calypte Biomedical Corporation develops, manufactures, and distributes in vitro diagnostic tests, primarily for the diagnosis of Human Immunodeficiency Virus (HIV) infection. It is focused on the development and commercialization of the Aware HIV-1/2 rapid tests. Its product line includes the Aware line of rapid tests, the Aware HIV-1 BED Incidence test and the Aware Messenger specimen collection device.
| | (Source: 10-K)
|
|
|